Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery

Molecules

Volumn 19, Issue 9, 2014, Pages 13319-13331

  Shirazi, Amir Nasrolahi ^a   Paquin, Karissa L ^b   Howlett, Niall G ^b   Mandal, Dindyal ^a   Parang, Keykavous ^a  

^a CHAPMAN UNIVERSITY   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Cyclic peptides; Gold nanoparticles; SiRNA delivery systems (DDS); Small interfering RNA (siRNA) delivery

Indexed keywords

CELL PENETRATING PEPTIDE; CYCLOPEPTIDE; GOLD; METAL NANOPARTICLE; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; CHEMISTRY; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PROCEDURES;

AMINO ACID SEQUENCE; CELL-PENETRATING PEPTIDES; GENE KNOCKDOWN TECHNIQUES; GOLD; HELA CELLS; HUMANS; METAL NANOPARTICLES; PEPTIDES, CYCLIC; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84908146283     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190913319     Document Type: Article

References (35)

1. Sontheimer, E. J. Assembly and function of RNA silencing complexes. Nat. Rev. Mol. Cell Biol. 2005, 6, 127-138.
2. Song, E.; Lee, S. K.; Wang, J.; Ince, N.; Ouyang, N.; Min, J.; Chen, J.; Shankar, P.; Lieberman, J. RNA Interference targeting fas protects mice from Fulminant hepatitis. Nat. Med. 2003, 9, 347-351.
3. Sioud, M.; Sorensen, D. R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 2003, 312, 1220-1225.
4. Urban-Klein, B.; Werth, S.; Abuharbeid, S.; Czubayko, F.; Aigner, A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in Vivo. Gene Ther. 2005, 12, 461-466.
5. Jantscha, J.; Turzac, N.; Volkea, M.; Eckardta, K. U.; Henseld, M.; Steinkasserer, A.; Willama, C.; Prechtel, A. T. Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendritic cells by electroporation. J. Immunol. Methods 2008, 337, 71-77.
6. Brummelkamp, T. R.; Bernards, R.; Agami, R. Stable suppression of tumorigenicity by virusmediated RNA interference. Cancer Cell 2002, 2, 243-247.
7. Stewart, S. A.; Dykxhoorn, D. M.; Palliser, D.; Mizuno, H.; Yu, E. Y.; An, D. S.; Sabatini, D. M.; Chen, I. S.; Hahn, W. C.; Sharp, P. A.; et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003, 9, 493-501.
8. Dykxhoorn, D. M.; Lieberman, J. The Silent Revolution: RNA Interference as basic biology, research tool, and therapeutic. J. Annul. Rev. Med. 2005, 56, 401-423.
9. Ryther, R. C. C.; Flynt, A. S.; Phillips, J. A.; Patton, J. G. siRNA therapeutics: big potential from small RNAs. Gene Ther. 2005, 12, 5-11.
10. Rozema, D. B.; Lewis, D. L.; Wakefield, D. H.; Wong, S. C.; Klein, J. J.; Roesch, P. L.; Bertin, S. L.; Reppen, T. W.; Chu, Q.; Blokhin, A. V.; et al. Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. USA 2007, 104, 12982-12987.
11. Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J.; et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432, 173-178.
12. Pushparaj, P. N.; Melendez, A. J. Short interfering RNA (siRNA) as a novel therapeutic. Clin. Exp. Pharmacol. Physiol. 2006, 33, 504-510.
13. McCarrol, J.; Baigude, H.; Yang, C. S.; Rana, T. M. Nanotubes functionalized with lipids and natural amino acid dendrimers: A new strategy to create nanomaterials for delivering systemic RNAi. Bioconjug. Chem. 2010, 21, 56-63.
14. Behlke, M. A. Progress towards in vivo use of siRNAs. Mol. Ther. 2006, 13, 644-670.
15. Ma, H.; Zhu, J.; Maronski, M.; Kotzbauer, P. T.; Lee, V. M.; Dichter, M. A.; Diamond, S. L. Non-classical nuclear localization signal peptides for high efficiency lipofection of primary neurons and neuronal cell lines. Neuroscience 2002, 112, 1-5.
16. McManus, M. T.; Haines, B. B.; Dillon, C. P.; Whitehurst, C. E.; van Parijs, L.; Chen, J.; Sharp, P. A. Small interfering rna-mediated gene silencing in T lymphocytes. J. Immunol. 2002, 169, 5754-5760.
17. Strait, K. A.; Stricklett, P. K.; Kohan, J. L.; Miller, M. B.; Kohan, D. E. Identification of two Nuclear factor of activated T-cells (NFAT)-response elements in the 5'-upstream regulatory region of the ET-1 promoter. Am. J. Physiol. 2007, 293, 601-606.
18. Wang, S.; Bui, V.; Hughes, J. A.; King, M. A.; Meyer, E. M. Adeno-associated virus mediated gene transfer into primary rat brain neuronal and glial cultures: Enhancement with the pH-sensitive surfactant dodecyl 2-(1wiimidazolyl) propionate. Neurochem. Int. 2000, 37, 1-6.
19. Ohki, E. C.; Tilkins, M. L.; Ciccarone, V. C.; Price, P. J. Improving the transfection efficiency of post-mitotic neurons. J. Neurosci. Methods 2001, 112, 95-99.
20. Mandal, D.; Nasrolahi Shirazi, A.; Parang, K. Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters. Angew. Chem. Int. Ed. 2011, 50, 9633-9637.
21. Lewin, M.; Carlesso, N.; Tung, C. H.; Tang, X. W.; Cory, D.; Scadden, D. T.; Weissleder, R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000, 18, 410-414.
22. Josephson, L.; Tung, C. H.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates. Bioconjug. Chem. 1999, 10, 186-191.
23. Liang, J. F.; Yang, V. C. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity. Bioorg. Med. Chem. Lett. 2005, 15, 5071-5075.
24. Rothbard, J. B.; Garlington, S.; Lin, Q.; Kirschberg, T.; Kreider, E.; McGrane, P. L.; Wender, P. A.; Khavari, P. A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 2000, 6, 1253-1257.
25. Shirazi, N. A.; Tiwari, R. K.; Oh, D.; Banerjee, A.; Yadav, A.; Parang, K. Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine. Mol. Pharm. 2013, 10, 2008-2020.
26. Torchilin, V. P.; Rammohan, R.; Weissig, V.; Levchenko, T. S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 2001, 98, 8786-8791.
27. Khalil, I. A.; Kogure, K.; Futaki, S.; Harashima, H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 2006, 281, 3544-3551.
28. Morgan, M. T.; Nakanishi, Y.; Kroll, D. J.; Griset, A. P.; Carnahan, M. A.; Wathier, M.; Oberlies, N. H.; Manikumar, G.; Wani, M. C.; Grinstaff, M. W. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res. 2006, 66, 11913-11921.
29. Duncan, B.; Kim, C.; Rotello, V. M. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J. Control. Release 2010, 148, 122-127.
30. Kumar, P. Ban, H-S.; Kim, S-S, Wu, H.; Pearson, T.; Greiner, D-L.; Laouar, A.; Yao, J.; Haridas, V.; Habiro, K.; et al. T Cell-specific sirna delivery suppresses hiv-1 infection in humanized mice. Cell 2008, 134, 577-586.
31. Kumar, P.; Haoquan, W.; McBride, J.-L.; Jung, K.-E.; Kim, M.-H.; Davidson, B.-L.; Lee, S.-K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448, 39-43.
32. Oh, D.; Shirazi, N. A.; Northup, K.; Sullivan, B.; Tiwari, R. K.; Bisoffi, M.; Parang, K. Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization. Mol. Pharm. 2014, 11, 2845-2854.
33. Shirazi, N. A.; Tiwari, R. K.; Chhikara, B. S.; Mandal, D.; Parang, K. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs. Mol. Pharm. 2013, 10, 488-499.
34. Shirazi, N. A.; Tiwari, R. K.; Oh, D.; Sullivan, B.; McCaffrey, K.; Mandal, D.; Parang, K. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters. Mol. Pharm. 2013, 10, 3137-3151.
35. Shirazi, N. A.; Mandal, D.; Tiwari, R. K.; Guo, L.; Lu, W.; Parang, K. Cyclic peptide-capped gold nanoparticles as drug delivery systems. Mol. Pharm. 2013, 10, 500-511.